1AD I am in
• Phase I extension study of AD-214 tested the target Phase II dose of AD-214 in healthy volunteers
• Results positively answer key partnering discussion questions and support progressing AD-214 to Phase II clinical studies in Idiopathic Pulmonary Fibrosis (IPF)
Add to My Watchlist
What is My Watchlist?